Morepen Laboratories Ltd
NSE:MOREPENLAB

Watchlist Manager
Morepen Laboratories Ltd Logo
Morepen Laboratories Ltd
NSE:MOREPENLAB
Watchlist
Price: 34.95 INR 2.85%
Market Cap: ₹19.2B

Operating Margin

5.2%
Current
Declining
by 1.1%
vs 3-y average of 6.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.2%
=
Operating Income
₹915.4m
/
Revenue
₹17.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.2%
=
Operating Income
₹915.4m
/
Revenue
₹17.6B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Morepen Laboratories Ltd
NSE:MOREPENLAB
19B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...

Market Distribution

In line with most companies in India
Percentile
41th
Based on 5 437 companies
41th percentile
5.2%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Morepen Laboratories Ltd
Glance View

Market Cap
19.2B INR
Industry
Pharmaceuticals

Morepen Laboratories Ltd. engages in the manufacture and market of bulk drugs and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The firm is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also the home health products. Its APIs include Apixaban, Edoxaban, Sitagliptin, Linagliptin, Empagliflozin, Atorvastatin, Loratadine, Desloratadine, Montelukast Sodium, Atorvastatin Calcium, Fexofenadine, Sitagliptin Phosphate, Vildagliptin and Rivaroxaban, among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen 49W Room Air Purifier With HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor Nebulizer and Dr. Morepen ST03 Dual Head Stethoscope, among others. Its subsidiaries include Dr. Morepen Limited and Total Care Limited, among others.

MOREPENLAB Intrinsic Value
40.44 INR
Undervaluation 14%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
5.2%
=
Operating Income
₹915.4m
/
Revenue
₹17.6B
What is Morepen Laboratories Ltd's current Operating Margin?

The current Operating Margin for Morepen Laboratories Ltd is 5.2%, which is below its 3-year median of 6.3%.

How has Operating Margin changed over time?

Over the last 3 years, Morepen Laboratories Ltd’s Operating Margin has increased from 4.5% to 5.2%. During this period, it reached a low of 3.6% on Mar 31, 2023 and a high of 9.6% on Sep 30, 2024.

Back to Top